We know that Maverick Citizen respects and protects the crucial role of the South Africa Health Products Regulatory Authority (SAHPRA) in ensuring efficacy and safety of medicines. However, where the need is urgent and immediate, we also think that public debate of the evidence on which its decisions are based is also important. The use of Ivermectin is a case in point.
Here, a frontline intensive care doctor explains why he thinks there are strong medical grounds to make ivermectin available for compassionate use.
Between 21 December 2020 and 9 January 2021 South Africa recorded a further 8,100 deaths from Covid-19 and a total of 292,260 new cases. This means we have had: an average of 13,917 new cases daily and an average of 386 deaths per day.
Jan 13 2021 Read 487 Times
Doctors, nutritionists, scientists and frontline workers from over 50 countries have pledged their support to the now international ‘vitaminC4Covid’ campaign that aims to get vitamin C taken seriously both for the prevention and treatment of Covid-19.
Despite over 100 studies and 45 in the pipeline for the treatment and prevention of Covid-19, governments and Covid advisors appear united in ignoring the ‘elephant in the room’, i.e. why is it that 98% of people infected with Covid-19 have only a mild infection and only 2% are critically ill? What is the difference?
There is already more than enough evidence that vitamin C status, perhaps even more than vitamin D, makes a big difference. Vitamin C, unlike vitamin D, is rapidly depleted during viral infection and both vitamin C and the anti-inflammatory hormone cortisol are released by the adrenal glands when under attack.
email article
The group led by three physicians with a knack for making headlines posted its own review and meta-analysis of the global ivermectin literature on its website.
They maintain that ivermectin has a special combination of anti-viral and anti-inflammatory properties that make it useful preventively and for treating early and late-stage illness.
Too good to be true? Not in the mind of FLCCC co-leader Paul Marik, MD, chief of pulmonary and critical care medicine at Eastern Virginia Medical School in Norfolk, who co-authored the review and meta-analysis based mainly on studies from outside the U.S. People are dying, Marik said during a phone interview. We treat patients at the bedside. We don t have the ivory tower syndrome where you tell people what to do though you have no idea what you re doing.
Sunday, January 03, 2021 by: Divina Ramirez
Bypass censorship by sharing this link:
https://www.afinalwarning.com/482957.html (Natural News) Scientists worldwide are still testing numerous drugs that can be repurposed for treating COVID-19. But one antiparasitic drug called Ivermectin is being touted as a very promising medicine for the disease.
During a recent Senate hearing, physicians called on the government to swiftly review the expansive medical evidence on Ivermectin as an early treatment for COVID-19.
The hearing held Tuesday, Dec. 8, was the latest effort by the Republican chairman of the homeland security committee, Sen. Ron Johnson of Wisconsin, to discuss early treatment options for COVID-19 in the hopes of reducing hospitalizations and preventing deaths.
Nathan Butters, a 42-year-old lawyer-turned-medical student at the University of New Mexico, knows heâs putting some part of himself â his reputation, his possible future as a doctor â at risk.
But he canât help it, he said: If what he believes about a possible COVID-19 treatment turns out to be true, he would be helping others by advocating for its use.
âIâve been trying since July to get people in New Mexicoâ â from Governorâs Office officials to Human Services Secretary David Scrase â âto pay attention to this treatment, this drug,â Butters said. âPeople just tell me, âOh, there arenât enough studies; there are no control groups.â Thereâs a lot of resistance because it hasnât been blessed by the FDA, the CDC, the NIH â by the powers that be.â